Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

RHI Magnesita India Ltd.

RHI Magnesita

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
11 06 2021 Scheme of Arrangement Inter alia, to consider, inter alia, the following matters: 1) To take note of the order of the Hon ble National Company Law Tribunal, Mumbai Bench, Mumbai (“NCLT”) dated 5 May, 2021 sanctioning and approving the Composite Scheme of Amalgamation of RHI India Private Limited (“Transferor Company 1”), RHI Clasil Private Limited (“Transferor Company 2”) and Orient Refractories Limited (“Company”) and their respective shareholders and creditors (“Scheme”) as well as receipt by the Company of the certified copy of the order of the Hon ble NCLT sanctioning the Scheme and to also take note of the effective date of the Scheme as 7 June, 2021 i.e. date of receipt of the certified copy of the order of the Hon’ble NCLT. 2) To consider and approve the allotment ofshares of the Company to the equity shareholders of the Transferor Company 1 and the Transferor Company 2 in consideration of their amalgamation with the Company pursuant to and in the manner as approved in the Scheme as sanctioned by the Hon ble NCLT and to fix the record date for ascertaining the eligible shareholders of the Transferor Company 1 and Transferor Company 2 and to do all other things incidental and ancillary thereto, including filing of the application seeking listing and trading permission of the shares issued pursuant to Scheme. 3) To consider and approve change of name of the Company pursuant to and in accordance with the approved Scheme as sanctioned by the Hon ble NCLT
25 06 2021 Final Dividend & Audited Results
11 08 2021 Quarterly Results
12 11 2021 Quarterly Results
10 02 2022 Quarterly Results
27 05 2022 Final Dividend & Audited Results
10 08 2022 Quarterly Results
09 11 2022 Quarterly Results
19 11 2022 Preferential Issue of shares Inter alia, to consider the issue of equity shares of the Company by way of preferential allotment, in accordance with the applicable laws and shall be subject to such regulatory/ statutory approvals, as may be required, including the approval of the shareholders of the Company. Further, wthe Company proposes to seek Members? approval for the said proposal in due course by way of Postal Ballot/ Extraordinary General Meeting.
04 01 2023 Inter alia, to issue and allot 2,70,00,000 equity shares of the Company on preferential basis to DBRL.
05 01 2023 (Revised) The meeting of Board of Directors of the Company that wasscheduled to be held on Wednesday, 4 January 2023 is rescheduled due to unavoidable reasons/ circumstances andnow will take place on Thursday, 5 January 2023, inter alia, to issue and allot 2,70,00,000 equity shares of the Company on preferential basis to Dalmia Bharat Refractories Limited.
13 02 2023 Quarterly Results & Preferential Issue of shares & Inter alia, will also consider and approve raising further capital and to create, offer, issue and allot such number of equity shares, and/ or securities convertible into Equity Shares , and/ or securities linked to Equity Shares, and/ or any instrument or securities representing Equity Shares, and/ or convertible securities linked to Equity Shares (all of which are hereinafter collectively referred to as ?Securities?) or any combination of Securities, by way of qualified institutions placement, further public offering and/or combination thereof as may be considered appropriate or any other permissible mode, in one or more tranches, in accordance with the SEBI ICDR, as amended, and all other applicable laws, as may be considered appropriate, subject to shareholders approval and government/ regulatory/ statutory approvals and requirements, as applicable.
01 04 2023 Preferential Issue of shares & Inter alia to consider and approve the proposal for raising of funds by way of a preferential allotment by way of issue of equity shares to its promoters and / or the members of the promoter group of the Company for an aggregate amount not exceeding Rs. 2,000 million, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and all other applicable laws, as may be considered appropriate, subject to the necessary government / regulatory / statutory approvals and requirements, as may be required including the approval of the shareholders of the Company
30 05 2023 Quarterly Results & Final Dividend & Audited Results
10 08 2023 Quarterly Results
08 11 2023 Quarterly Results
13 02 2024 Quarterly Results
07 11 2024 Quarterly Results
11 02 2025 Quarterly Results
28 05 2025 Final Dividend & Audited Results
08 08 2025 Quarterly Results
10 11 2025 Quarterly Results
13 02 2026 Quarterly Results

News

05-MAR-2025

RHI Magnesita India’s arm inks SPA with Ashwath Technologies

Intermetal Engineers will acquire 100% stake in Ashwath Technologies for total consideration of Rs 14 crore

02:30 PM
12-AUG-2023

RHI Magnesita India makes further investment in RHI Magnesita India Refractories

The subscription of equity shares of RHI Magnesita India Refractories by the company for the purpose of repayment or pre-payment, in full or in part, of certain borrowings

10:29 AM
25-JUL-2023

RHI Magnesita India’s arm acquires balance 49% stake in RHIM Seven

Consequent to the above, the RHIM Seven has become the 100% wholly owned subsidiary of DOCL with effect from July 24, 2023

09:41 AM
09-MAY-2023

RHI Magnesita India makes additional investment in Dalmia OCL

The subscription of equity shares of DOCL by the Company for the purpose of repayment or pre-payment, in full or in part, of certain borrowings availed by DOCL

10:00 AM
24-APR-2023

RHI Magnesita India’s arm to acquire balance 49% stake in RHIM Seven

DOCL already owns 51% paid up equity shares of RHIM Seven and will own 100% paid up equity shares of RHIM Seven following completion of the acquisition

10:49 AM
21-FEB-2023

RHI Magnesita to invest Rs 3,600 crore in Indian market for capacity expansion

The RHI Magnesita group will do the capital infusion through its subsidiary RHI Magnesita India

12:00 PM
21-NOV-2022

RHI Magnesita to acquire Indian refractory business of Dalmia Bharat Refractories

The acquisition will significantly increase RHI Magnesita’s presence in the fast-growing Indian refractory market

12:00 PM
19-OCT-2022

RHI Magnesita India executes business transfer agreement with Hi-Tech Chemicals

The Object of acquisition is to strengthen and enlarge offering to enhance the Company’s position in the domestic & international flow-control refractory business

11:38 AM
Enrich money logo